Select Medical Holdings Co. (NYSE:SEM) Director Marilyn B. Tavenner Sells 32,000 Shares

Select Medical Holdings Co. (NYSE:SEM) Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the transaction, the director now owns 22,000 shares of the company’s stock, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Select Medical Trading Up 3.7 %

Shares of SEM opened at $21.11 on Friday. The stock has a fifty day moving average price of $34.11 and a two-hundred day moving average price of $34.71. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a market cap of $2.73 billion, a price-to-earnings ratio of 9.86, a PEG ratio of 0.91 and a beta of 1.42. Select Medical Holdings Co. has a 52-week low of $20.00 and a 52-week high of $40.98.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. During the same period in the previous year, the business posted $0.46 earnings per share. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. Analysts predict that Select Medical Holdings Co. will post 2.16 EPS for the current fiscal year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were issued a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s dividend payout ratio is currently 23.36%.

Wall Street Analyst Weigh In

SEM has been the subject of a number of recent research reports. Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Bank of America initiated coverage on Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective for the company. Royal Bank of Canada boosted their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, StockNews.com downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Select Medical presently has a consensus rating of “Hold” and a consensus price target of $40.75.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP raised its position in shares of Select Medical by 2.2% during the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock worth $157,728,000 after acquiring an additional 95,578 shares during the last quarter. Geode Capital Management LLC increased its position in Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after purchasing an additional 46,880 shares during the period. Principal Financial Group Inc. raised its holdings in Select Medical by 6.7% during the 3rd quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after purchasing an additional 147,032 shares during the last quarter. Point72 Asset Management L.P. lifted its position in Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Select Medical by 1.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock valued at $57,407,000 after purchasing an additional 24,439 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.